Detalles de la búsqueda
1.
Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Lancet Oncol
; 13(3): 292-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22336221
2.
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.
Lancet
; 374(9699): 1432-40, 2009 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-19767093
3.
KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis.
Cancer Treat Res Commun
; 24: 100200, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750661
4.
A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER.
Front Oncol
; 10: 578756, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33194700
5.
Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.
Curr Med Res Opin
; 34(5): 865-871, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29424248
6.
Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study.
Clin Cancer Res
; 24(22): 5543-5551, 2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30082474
7.
Safety profiles of non-small cell lung cancer patients treated with pemetrexed plus carboplatin: a real-world retrospective, observational, cohort study.
Curr Med Res Opin
; 33(5): 931-936, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28276253
8.
Systematic Review of Brain Metastases in Patients With Non-Small-Cell Lung Cancer in the United States, European Union, and Japan.
Clin Lung Cancer
; 18(6): 607-614, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28571688
9.
Meta-analysis of pemetrexed plus carboplatin doublet safety profile in first-line non-squamous non-small cell lung cancer studies.
Curr Med Res Opin
; 33(5): 937-941, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28277871
10.
Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients.
J Med Econ
; 20(2): 151-161, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27574722
11.
Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer.
Lung Cancer
; 52(2): 173-80, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16507327
12.
Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.
Clin Colorectal Cancer
; 5(3): 181-7, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16197621
13.
The emerging role of antifolates in the treatment of malignant pleural mesothelioma.
Semin Oncol
; 29(1): 77-81, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11836672
14.
Expression levels of protein kinase C-alpha in non-small-cell lung cancer.
Clin Lung Cancer
; 6(3): 184-9, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15555220
15.
A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer.
Cancer Manag Res
; 6: 437-49, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25364274
16.
Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study.
J Thorac Oncol
; 9(7): 991-997, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24926544
17.
PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
J Clin Oncol
; 31(34): 4349-57, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24145346
18.
A randomized, double-blind, phase III study of Docetaxel and Ramucirumab versus Docetaxel and placebo in the treatment of stage IV non-small-cell lung cancer after disease progression after 1 previous platinum-based therapy (REVEL): treatment rationale and study design.
Clin Lung Cancer
; 13(6): 505-9, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22853980
19.
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.
J Clin Oncol
; 24(9): 1428-34, 2006 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16549837
Resultados
1 -
19
de 19
1
Próxima >
>>